Latest News
JPM 2025: J&J snaps up neuroscience biotech Intra-Cellular for $14.6bn
JPM 2025: J&J snaps up neuroscience biotech Intra-Cellular for $14.6bn
Johnson & Johnson got the JP Morgan Healthcare Conference off to a flying start with its $14.6 billion Intra-Cellular Therapies buy.
BIO-EUROPE COVERAGE
BIO-EUROPE COVERAGENews from APAC
See allC-Suite Conversations
See allpartneringONE’s first-in-class partnering technology powers global events and enhances your networking experience.
BioXconomy presents the Asia biopharma and healthcare dealmaking and financing news for the week ending 5 January.
Ashley Volz, Digital Product Manager for Informa Life Sciences, sits down with Simon Fagg, Founder of coaching and training organization With Leadership, to discuss how biotech companies can best present themselves and their story to the investment and partnering community.
MFX, Tolemy Bio, and AminoAcids.com join forces to advance model-driven media optimization for cell and gene therapies.